Finding events near you ...

Past Events

May
30
  1.   Global initiatives
  2.    Public
  1.   30th May, 2017 - 1st Jun, 2017
Immunization and Vaccines-related Implementation Research Advisory (IVIR) Committee meeting
  1.   1
  2.   Geneva, Switzer...
May
23
  1.   Service delivery
  2.    Public
  1.   23rd May, 2017 - 25th May, 2017
Training of consultants and partners on the updated WHO strategy to reduce Missed Opportunities for Vaccination (MOVs)
  1.   1
May
08
  1.   8th May, 2017 - 19th May, 2017
Capacity building workshop on Data quality review, Immunization information system, data quality improvement and revised survey methodology for 22 remaining Gavi eligible countries
  1.   1
  2.   Kigali, Rwanda...
May
08
  1.   8th May, 2017 - 12th May, 2017
Developing Countries Vaccine Manufacturers Network (DCVMN) Training Workshop in Vaccine Safety and Pharmacovigilance Strategies.
  1.   1
  2.   Beijing, China...
Mar
30
  1.   30th Mar, 2017
In this webinar, the speaker will share lessons learned from the process of developing and implementing the Expanded Program on Immunization (EPI) Data Management System in Cameroon. The presentation...
In this webinar, the speaker will share lessons learned from the process of developing and implementing the Expanded Program on Immunization (EPI) Data Management System in Cameroon. The presentation will expound on the tools that were applied, the actors at play and the approach taken. Our speaker will further explain the challenges encountered during the process and changes made to overcome them by highlighting critical areas of prioritization.
  1.   2
Oct
16
  1.   16th Oct, 2017 - 20th Oct, 2017
The 15th TechNet Conference will be held in Cascais, Portugal from October 16th to 20th. For more information, please visit the TechNet Conference webpage.
  1.   42
  2.   Av. Marginal 85...
Sep
08
  1.   Service delivery
  2.    Public
  1.   8th Sep, 2017 - 10th Sep, 2017
ESCMID is concerned that a lack of evidence-based information among healthcare providers and the lay public may undermine the efficacy of future vaccination campaigns. As part of its multidisciplinary...
ESCMID is concerned that a lack of evidence-based information among healthcare providers and the lay public may undermine the efficacy of future vaccination campaigns. As part of its multidisciplinary approach to fight infections, ESCMID is committed to improve the scientific basis for vaccines and optimize their use in the healthcare setting. This conference is set to bring together leading experts who will present and debate the most recent data to develop strategies that will help protect generations to come from vaccine-preventable diseases.
  1.   1
  2.   Dubrovnik, Croa...
May
23
  1.   Service delivery
  2.    Public
  1.   23rd May, 2017 - 25th May, 2017
AFRO East and South Regional Working Group
  1.   1
  2.   Maputo, Mozambi...
Apr
20
  1.   Service delivery
  2.    Public
  1.   20th Apr, 2017 - 23rd Apr, 2017
EPI Managers’ Meeting for East & Southern Africa
  1.   1
  2.   Kampala, Uganda...
Apr
18
  1.   Programme management
  2.    Public
  1.   18th Apr, 2017 - 21st Apr, 2017
Sharing lessons learned on Vaccination Coverage Surveys and defining a surveyrelated
Research agenda
  1.   1
  2.   Geneva, Switzer...
Mar
29
  1.   29th Mar, 2017 - 30th Mar, 2017
HSV Vaccine Preferred Product Characteristics Global Stakeholder Consultation
  1.   1
  2.   Geneva, Switzer...
Mar
22
  1.   Service delivery
  2.    Public
  1.   22nd Mar, 2017 - 23rd Mar, 2017
immunization in the elderly meeting
  1.   1
  2.   Geneva, Switzer...
Mar
06
  1.   6th Mar, 2017
Interested in learning what the new HPV vaccination series recommendations means for your practice? Unsure of how to best address commonly asked questions about HPV vaccinations from parents? Want to ...
Interested in learning what the new HPV vaccination series recommendations means for your practice? Unsure of how to best address commonly asked questions about HPV vaccinations from parents? Want to know more about how to increase HPV vaccination rates among your patient population? Join a panel of experts in pediatric primary care, infectious diseases, obstetrics and gynecology and ear, nose and throat for an HPV vaccination update webinar. Experts will cover a range of topics related to HPV vaccination, including the latest trends in HPV disease prevalence and prevention.
  1.   1
Feb
23
  1.   General
  2.    Public
  1.   23rd Feb, 2017
With the publication of the new book The Politics of Fear: Médecins Sans Frontières and the West African Ebola Epidemic, MSF provides a deeper reflection around the response to the outbreak in 2014-20...
With the publication of the new book The Politics of Fear: Médecins Sans Frontières and the West African Ebola Epidemic, MSF provides a deeper reflection around the response to the outbreak in 2014-2015. What was the motivation for some of the response decisions? Were there effective medical advances that emerged from the intervention? What lessons did MSF take away from the largest mobilization in the organization’s history? What are the lingering needs in the countries whose health infrastructures were severely compromised by the outbreak? And is the world ready for the next outbreak of Ebola or other infectious diseases? They will also share information on the post-Ebola medical needs in Liberia, Sierra Leone, and Guinea, and how MSF is addressing them.
  1.   1
Apr
24
  1.   Global initiatives
  2.    Public
  1.   24th Apr, 2017 - 30th Apr, 2017
World Immunization Week – celebrated in the last week of April – aims to promote the use of vaccines to protect people of all ages against disease. Immunization saves millions of lives and is widely r...
World Immunization Week – celebrated in the last week of April – aims to promote the use of vaccines to protect people of all ages against disease. Immunization saves millions of lives and is widely recognized as one of the world’s most successful and cost-effective health interventions. Today, there are still 19.4 million unvaccinated and under-vaccinated children in the world.
  1.   1
May
22
  1.   22nd May, 2017 - 24th May, 2017
Recognition of the skin by vaccinologists as an ideal anatomical target has gathered momentum in the past decade. The premise that the dense population of APCs can be targeted, stimulated and loaded w...
Recognition of the skin by vaccinologists as an ideal anatomical target has gathered momentum in the past decade. The premise that the dense population of APCs can be targeted, stimulated and loaded with antigens to induce robust immune responses and result in more efficacious vaccines has stimulated many efforts to understand skin physiology, the skin immune system antigen presenting cells, effector responses and modes of immune stimulation and delivery formats. The field is ripe to have broad interchange on relevant related disciplines to focus both research and development efforts on more effective and informative directions. With several products in late stage development and a newly licensed delivery device, a timely multi disciplinary interchange is greatly needed to help set the stage for progress that can lead to capitalizing on the immunopotency of the skin to bring about better human health.
  1.   1
  2.   Leiden, Netherl...
Feb
01
  1.   1st Feb, 2017
Hosted by the Life-Saving Commodities Practitioners' Network, on 1st February, 2:30 GMT (6:30 am PST, 9:30 am EST, 3:30 pm WAT and 5:30 pm EAT). Hitesh Hurkchand from the RMNCH Strategy and Coordin...
Hosted by the Life-Saving Commodities Practitioners' Network, on 1st February, 2:30 GMT (6:30 am PST, 9:30 am EST, 3:30 pm WAT and 5:30 pm EAT).

Hitesh Hurkchand from the RMNCH Strategy and Coordination Team will present the work that the Interagency Supply Chain Group has undertaken to support country efforts in ensuring sustainable access to high quality essential health commodities.

He will look at the lessons learned from Senegal, Ethiopia, Tanzania, Zambia, Nigeria and Myanmar.
  1.   1
Nov
30
  1.   30th Nov, 2017 - 1st Dec, 2017
Theme: Innovative Therapeutic Strategies in Vaccines & Vaccination Track 1: Vaccine development: Vaccine research is long, complex and costly. Because a vaccine is a biological product made from l...
Theme: Innovative Therapeutic Strategies in Vaccines & Vaccination

Track 1: Vaccine development:
Vaccine research is long, complex and costly. Because a vaccine is a biological product made from living microorganisms, its development method is quite different from that of a pharmaceutical method. Approximately 70% of production time is dedicated to quality control, Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. Vaccine development and testing follow a standard set of steps.
1. Laboratory Studies and Animal Studies: Exploratory Stage, Pre-clinical Stage, IND Application
2. Clinical Studies with Human Subjects: Phase I Vaccine Trials, Phase II Vaccine Trials, Phase III Vaccine Trials,
3. Approval and Licensure
4. Post-Licensure Monitoring of Vaccines
5. Phase IV Trials

VAERS: The Vaccine Adverse Event Reporting System


Track 2: Vaccine Business:

The Evolution in the Vaccines market continues with strong growth and new prospects to continue the growth in Vaccines market, which now stands at about $25 billion. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate projects, with some segments like adult vaccines showing even better.
  1.   1
  2.   Dubai - United ...
Sep
18
  1.   18th Sep, 2017 - 19th Sep, 2017
Theme: A New Era in Vaccines research & Development. Topics: Recombinant vector vaccines, Subunit vaccines, conjugate Vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, He...
Theme: A New Era in Vaccines research & Development. Topics: Recombinant vector vaccines, Subunit vaccines, conjugate Vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, Heterotypic Vaccines, monovalent/ univalent/ multivalent/polyvalent Vaccines, innovative vaccines, inactivated (killed antigen), subunit (purified antigen), Toxins (inactivated Toxins), recombinant subunit vaccine, Developing immunity, Trends in Vaccine Development, History of Vaccines, Effectiveness of Vaccines, History of Vaccines Development, Expectations Towards Safety of Vaccines, vaccine preventable diseases, vaccine safety in immunization programmes, vaccine regulations, pre-licensure vaccine safety, post-licensure vaccine safety, balancing vaccines efficacy and safety, etc.
  1.   1
  2.   Houston, TX, US...
Aug
21
  1.   21st Aug, 2017 - 23rd Aug, 2017
Deliberation on modern vaccine research and development focusing on vaccine design, delivery and evaluation
  1.   1
  2.   Birmingham, UK...
There are no past events.
Unable to load tooltip content.